Aridis Pharmaceuticals Inc (NASDAQ:ARDS) shares are trading lower by 23.34% to $0.42 Tuesday morning after the company announced a $2.28 million registered direct offering.
The company has entered a definitive agreement for the issuance and sale of an aggregate of 6 million shares of the company's common stock at a purchase price of $0.38 per share.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
See Also: Why BuzzFeed (BZFD) Stock Is Falling Today
Aridis Pharmaceuticals currently intends to use the net proceeds from the offering for working capital and general corporate purposes.
According to data from Benzinga Pro, ARDS has a 52-week high of $2.77 and a 52-week low of $0.35.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.